About Lab Direct
Lab Direct is a company based in Shanghai (China) founded in 2015. Lab Direct has raised $10 million across 2 funding rounds from investors including Morimatsu, Long Hill Capital and Free Trade One. Lab Direct operates in a competitive market with competitors including Bionexo, Global Healthcare Exchange, VPL, Clarium and Curvo, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 2 rounds
-
Latest Funding Round
$10 M (USD), Series A
Aug 26, 2022
-
Investors
Morimatsu
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lab Direct
Lab Direct has successfully raised a total of $10M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Lab Direct
Lab Direct has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Morimatsu, Long Hill Capital and Free Trade One.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech and offline sectors in China are targeted for investments.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Lab Direct
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lab Direct
Investment portfolio details for Lab Direct
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lab Direct
Detailed financials for Lab Direct
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lab Direct Comparisons
Peer comparison for Lab Direct
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lab Direct
Lab Direct operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bionexo, Global Healthcare Exchange, VPL, Clarium and Curvo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Supply chain management solutions for hospitals
|
|
| Locked | Locked | Locked |
Supply chain solutions for healthcare industry are provided.
|
|
| Locked | Locked | Locked |
SaaS supply chain management software is provided for life sciences.
|
|
| Locked | Locked | Locked |
Supply chain automation tools for hospitals are developed using AI.
|
|
| Locked | Locked | Locked |
Cloud-based supply chain platforms are offered for healthcare organizations.
|
|
| Locked | Locked | Locked |
Cloud-based workflow management solutions are offered for healthcare organizations.
|
Detailed competitors of Lab Direct
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lab Direct
Complete news archive for Lab Direct
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lab Direct
Lab Direct was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Lab Direct is headquartered in Shanghai, China.
Lab Direct is a funded company, having raised a total of $10M across 2 funding rounds to date.
Lab Direct was founded in 2015 and is based in Shanghai, China. Operations focus on the laboratory sector, where specialized formulation development services are delivered alongside reagents, consumables, and instruments. Products such as ammonium formate, alizarin red, acetylphthalide, neutral alumina, and DL-arginine hydrochloride are supplied to support research and development activities in various scientific applications.
Lab Direct's top competitors include Global Healthcare Exchange, Clarium and VPL.
Lab Direct has 3 investors. Key investors include Morimatsu, Long Hill Capital, and Free Trade One.